Drug Trial Radar · NCT00223080
HIV Vaccine Trial in Thai Adults
Last checked: Nov 20, 2026Latest source record: Apr 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16,402
Actual
Start
Oct 2003
Primary completion
Jul 2006
Study completion Jun 2009
Sponsor
- Lead sponsor
- U.S. Army Medical Research and Development CommandFederal agency
- Sponsor type
- Federal agency
- Collaborators
- United States Army Medical Materiel Development Activity; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research (WRAIR); MCM Vaccines B.V.; VaxGen; The Emmes Company, LLC; Ministry of Health, Thailand; Mahidol University; Royal Thai Army Medical Department; Tripler Army Medical Center; Henry M. Jackson Foundation for the Advancement of Military Medicine
- First posted
- Sep 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 30 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether immunizations with an integrated combination of ALVAC-HIV (vCP1521) boosted by AIDSVAX gp120 B/E prevent HIV infection in healthy Thai volunteers.
Conditions
- HIV Infection
Interventions
ALVAC-HIV vCP1521 + AIDSVAXBiological
Combined dose of 600 μg (300 μg of each antigen), co-formulated and administered in alumi-um hydroxide gel at a dose of 600 μg/mL
ALVAC Placebo + AIDSVAX PlaceboOther
ALVAC carrier, supplied as a lyophilized product, without virus and Aluminum hydroxide adjuvant, 1.2 mL per vial, given as a 1 mL injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Kaplan-Meier Estimate of HIV-1 Infection Rate in Intent to Treat PopulationTime frame: 42 Months
- Vaccine Efficacy as Determined by Acquisition of Infection in the Per-protocol PopulationTime frame: 42 Months
- Changes in HIV-1 Viral Load in Volunteers Developing HIV Infection During the Trial for the MITT PopulationTime frame: 42 months
- Changes in HIV-1 Viral Load in Volunteers Developing HIV Infection During the Trial for the Per Protocol PopulationTime frame: 42 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Ban Lamung District Hospital
Ban Lamung District, Changwat Chon Buri, Thailand
Phan Tong District Hospital
Phan Tong District, Changwat Chon Buri, Thailand
Sattahip District Hospital
Sattahip District, Changwat Chon Buri, Thailand
Ao Udom Hospital
Sri Racha District, Changwat Chon Buri, Thailand
Ban Chang District Hospital
Ban Chang District, Changwat Rayong, Thailand
Ban Khai District Hospital
Ban Khai District, Changwat Rayong, Thailand
Klaeng District Hospital
Klaeng District, Changwat Rayong, Thailand
Provincial Health Office
Muang District, Changwat Rayong, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.